Evidence map›Paper›PMID 40176069›Full record

ReviewEuropean journal of medical research2025

Intestinal barrier damage caused by addictive substance use disorder.

Yan Gao, Deshenyue Kong, Jia-Xue Sun, Zhong-Xu Ma, Guang-Qing Wang, Xing-Feng Ma, Liang Sun, Hua-You Luo, Yu Xu, Kun-Hua Wang

Abstract readReview
In one paragraph

Review in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Serum Zonulin Levels in Patients with Heroin Addiction.Sisli Etfal Hastanesi tip bulteni · 2026
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yan Gao *Yunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China.
Deshenyue Kong *Yunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China.
Jia-Xue Sun *Yunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China.
Zhong-Xu MaThird People's Hospital of Kunming City, Kunming, 650041, China.
Guang-Qing WangDrug Rehabilitation Administration of Yunnan Province, Kunming, 650032, China.
Xing-Feng MaDrug Rehabilitation Administration of Yunnan Province, Kunming, 650032, China.
Liang SunDepartment of Gastrointestinal and Hernia Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
Hua-You LuoDepartment of Gastrointestinal and Hernia Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China. 1677546296@qq.com.
Yu XuYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China. xiaoyuer52067@qq.com.
Kun-Hua WangYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China. wangkunhua1964@126.com.

Funding

the Kunming Medical University Joint Special Project 202401AY070001-241the Kunming Municipal Health Commission Health Science Research Project 2023-03-13-003the Yunnan Province "high-level talent training support program" training program YNWR-QNBJ-2019-243the Yunnan Technological Innovation Centre of Drug Addiction Medicine 202305AK340001
6 · The paper itself

Abstract

Addictive substance use disorder has a wide range of effects on the intestinal barrier, including damage to the biological, chemical, mechanical, and immune barriers. Damage to the intestinal barrier caused by addictive substance use disorder allows harmful substances and bacteria to cross the intestinal barrier into the circulatory system, leading to systemic inflammatory responses and immune imbalances. In addition, the interaction between the gut flora and the central nervous system is recognized as an important component of the gut-brain axis. Gut barrier damage leads to dysbiosis, which in turn affects brain function by activating immune cells and releasing inflammatory factors. This may lead to altered mood and cognitive function, increased addictive substance cravings, and dependence. Recent research has indicated that reshaping the gut-brain axis and adjusting the composition and abundance of gut microbiota holds promise in alleviating withdrawal symptoms with addictive substance dependence. This article reviews the effects of addictive substance use disorder on the intestinal barrier and explores the possibility of improving addictive substance dependence by treating gut barrier damage.

Indexed as

Gastrointestinal MicrobiomeIntestinal MucosaSubstance-Related DisordersAnimalsDysbiosisHumansAddictive substance use disorderGut floraIntestinal barrierThe gut–brain axis

Identifiers

PMID40176069
PMCPMC11963533

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.